deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT04429347

Gabapentin and Tizanidine for Insomnia in Chronic Pain

Effect of Gabapentin and Tizanidine on Insomnia in Chronic Pain Patients: A Randomized, Double-blind, Placebo-controlled Crossover Trial.

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Conditions Chronic Pain Insomnia Due to Medical Condition
Interventions Gabapentin Placebo Tizanidine
Updated 9 times since 2020 Last updated: Jan 1, 2025 Started: Jul 29, 2020 Primary completion: Dec 1, 2024 Completion: Dec 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Chronic Pain and Insomnia Due to Medical Condition and is currently completed. National Center for Advancing Translational Sciences (NCATS) leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshotNot Yet Recruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotEnrolling By Invitation~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotEnrolling By Invitation~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshotEnrolling By Invitation~Sep 2022 – ~Jan 2024 · 16 months · monthly snapshotEnrolling By Invitation~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotEnrolling By Invitation~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotEnrolling By Invitation~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotEnrolling By Invitation~Feb 2025 – present · 18 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Feb 2025 — Present [monthly]

    Completed PHASE2

    Status: Enrolling By Invitation → Completed

  2. Sep 2024 — Feb 2025 [monthly]

    Enrolling By Invitation PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Enrolling By Invitation PHASE2

  4. Jan 2024 — Jul 2024 [monthly]

    Enrolling By Invitation PHASE2

  5. Sep 2022 — Jan 2024 [monthly]

    Enrolling By Invitation PHASE2

▶ Show 4 earlier versions

  1. Sep 2021 — Sep 2022 [monthly]

    Enrolling By Invitation PHASE2

  2. Jan 2021 — Sep 2021 [monthly]

    Enrolling By Invitation PHASE2

  3. Aug 2020 — Jan 2021 [monthly]

    Enrolling By Invitation PHASE2

    Status: Not Yet Recruiting → Enrolling By Invitation

  4. Jul 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Center for Advancing Translational Sciences (NCATS)
  • University of California, San Diego
Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations